LBI Logo white bottom

News

Latest News

Jan 26, 2023

Longevity Biomedical, Inc. and Denali Capital Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

Investor Contact:

Kendall IR
Lauren Stival Hopfer
Lhopfer@Kendallir.Com
201-841-6116

Media Contact

Rathbun Communications
Julie Rathbun
julie@rathbuncomm.com
206-769-9219

LBI Logo white bottom

Longevity Biomedical, Inc
12100 NE 195th st. Suite 150
Bothell, WA 98011

+1 (425) 748-7529

info@longevitybiomedical.com

© 2022-2023 Longevity Biomedical Inc